Trials / Sponsors / Chengdu Kanghong Pharmaceutical Group Co., Ltd.
Chengdu Kanghong Pharmaceutical Group Co., Ltd.
Industry · 7 registered clinical trials — 6 currently recruiting.
| Status | Trial | Phase | Started |
|---|---|---|---|
| Not Yet Recruiting | Efficacy and Safety of KHN702 Tablets in Moderate to Severe Post-operative Pain Subjects Postoperative Pain | Phase 1 | 2025-12-01 |
| Not Yet Recruiting | A Phase 2 Study to Evaluate Efficacy and Safety of KH607 Tablets in Adult Participents With Major Depressive D Major Depressive Disorder (MDD) | Phase 2 | 2025-08-01 |
| Not Yet Recruiting | A Phase 2 Study to Evaluate Efficacy and Safety of KH607 Tablets in Woman With Postpartum Depression Postpartum Depressive Disorder | Phase 2 | 2025-07-01 |
| Not Yet Recruiting | A Phase 1 Study of KHN702 Tablets in Healthy Subjects Healthy | Phase 1 | 2025-06-21 |
| Not Yet Recruiting | A Double-Blind, Randomized Comparative Study of Carliprazine and Aripiprazole in Patients with Acute Schizophr Acute Schizophrenia | Phase 3 | 2024-10-01 |
| Recruiting | Phase 1 Study of KH607 Tablets Healthy | Phase 1 | 2023-10-21 |
| Unknown | Bioequivalence Study of Bosiqing and ABILIFY Under Fasting/Fed Condition Bioequivalence | N/A | 2017-06-26 |